Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients.
about
Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Increased PDGFR-beta and VEGFR ...... me of ovarian cancer patients.
@en
Increased PDGFR-beta and VEGFR ...... me of ovarian cancer patients.
@nl
type
label
Increased PDGFR-beta and VEGFR ...... me of ovarian cancer patients.
@en
Increased PDGFR-beta and VEGFR ...... me of ovarian cancer patients.
@nl
prefLabel
Increased PDGFR-beta and VEGFR ...... me of ovarian cancer patients.
@en
Increased PDGFR-beta and VEGFR ...... me of ovarian cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Increased PDGFR-beta and VEGFR ...... ome of ovarian cancer patients
@en
P2093
Barbara Schmalfeldt
Claudia Wolff
Holger Bronger
Katharina Malinowsky
Melanie Boxberg
Sibylle Gündisch
Stefanie Avril
Yasemin Dincer
P2860
P304
97851-97861
P356
10.18632/ONCOTARGET.18415
P407
P577
2017-06-08T00:00:00Z